Assessing factors related to the pharmacologic management of laryngeal diseases and disorders
Objectives/Hypothesis To examine how age, gender, comorbidity, geography, provider type,
and laryngeal pathology influence the use of pharmacological treatment in managing …
and laryngeal pathology influence the use of pharmacological treatment in managing …
联合大剂量缬沙坦对透析充分后顽固性高血压的疗效观察
李文宏， 殷玉敏， 何芸， 李慧， 刘军平 - 临床心血管病杂志, 2015 - whuhzzs.com
目的: 探讨维持血透(MHD) 患者透析充分后联合大剂量缬沙坦治疗顽固性高血压(RH)
的临床疗效及安全性. 方法: 选取MHD 合并透析充分后的RH 患者60 例, 随机分为试验组和对照 …
的临床疗效及安全性. 方法: 选取MHD 合并透析充分后的RH 患者60 例, 随机分为试验组和对照 …
Resistant hypertension or resistant prescribing?
ME Ernst - Hypertension, 2011 - Am Heart Assoc
The term “resistant hypertension”(RH) evokes a myriad of clinical descriptions, nearly all of
which implicitly ascribe origins of the problem to characteristics inherent within the patient or …
which implicitly ascribe origins of the problem to characteristics inherent within the patient or …
[HTML][HTML] Overview of resistant hypertension: A glimpse of the cardiologist's current standpoint
L Paiva, MC Cachulo, R Providencia… - World journal of …, 2012 - ncbi.nlm.nih.gov
Hypertension is a major risk factor for cardiovascular disease, resulting in increased
incidence of cerebrovascular events, ischaemic heart disease, heart failure, and renal …
incidence of cerebrovascular events, ischaemic heart disease, heart failure, and renal …
Drug therapy for the patient with resistant hypertension
L Donazzan, S Ewen, V Papademetriou… - Future …, 2015 - Taylor & Francis
Resistant hypertension is associated with high morbidity and mortality. Resistant
hypertension is defined as blood pressure above targets despite treatment with at least three …
hypertension is defined as blood pressure above targets despite treatment with at least three …
Itaconimides derivatives induce relaxation in mesenteric artery and negative inotropism by inhibition of CA2+ influx
RA Moraes, QL Alves, SB Camargo… - Pharmacological …, 2020 - Springer
Background The aim of this study was to evaluate the cardiovascular effects of N-phenyl-
itaconimide (Imide-1), N-4-methyl-phenyl-itaconimide (Imide-2), N-4-methoxy-phenyl …
itaconimide (Imide-1), N-4-methyl-phenyl-itaconimide (Imide-2), N-4-methoxy-phenyl …
[HTML][HTML] Resistant Hypertension in Patients With Type-2 Diabetes Mellitus: A Single-Center, Cross-Sectional Study
AS Binaqeel, HA Filimban, AA Fallatah, SW Bafageeh… - Cureus, 2022 - ncbi.nlm.nih.gov
Background The prevalence of resistant hypertension in Saudi patients with type-2 diabetes
mellitus (T2DM) has not been previously estimated. Therefore, our objective was to assess …
mellitus (T2DM) has not been previously estimated. Therefore, our objective was to assess …
Resistant Hypertension
H Boolani, A Sinha, O Randall - Current Cardiovascular Risk Reports, 2013 - Springer
Hypertension affects 25% of all adults worldwide and is a leading risk factor contributing to
62% of all strokes and 49% of all cases of heart disease, leading to an estimated 7.1 million …
62% of all strokes and 49% of all cases of heart disease, leading to an estimated 7.1 million …